FindTrial
Sign In

Effect of cerebral protective drugs on cognitive function in patients with traumatic brain injury during general anesthesia

Effect of cerebral protective drugs on cognitive function in patients with traumatic brain injury during general anesthesia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018993
Enrollment
Unknown
Registered
2018-10-20
Start date
2018-10-18
Completion date
Unknown
Last updated
2018-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

brain injury

Interventions

Group 1:Standard treatment
Group 2:cerebral protective medication

Sponsors

the Third Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients with brain injury receiving non craniocerebral operation under general anesthesia, American Society of Anesthesiologists' physical status classes I & II.

Exclusion criteria

Exclusion criteria: 1. Operation time is longer than 3 hours; 2. The intraoperative blood loss is more than 800ml; 3. The operation is cancelled for various reasons; 4. With history of neurological diseases and alcohol abuse; 5. With severe vision or hearing impairment and no obvious abnormality of heart, lung, liver and kidney function.

Design outcomes

Primary

MeasureTime frame
s100ß;GFAP;—

Countries

China

Contacts

Public ContactQiujun Wang

the Third Hospital of Hebei Medical University

13933178001@163.com+86 18533112929

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026